title: Discovering and developing PI3 kinase inhibitors for cancer: rapid progress through academic-biotech-pharma interactions.
authors.affiliation: Cancer Research UK Centre for Cancer Therapeutics, The Institute of Cancer Research, 15 Cotswold Road, Sutton, Surrey, SM2 5NG, United Kingdom. florence.raynaud@icr.ac.uk
authors.forename: Florence I
authors.initials: FI
authors.lastname: Raynaud
authors.forename: Paul
authors.initials: P
authors.lastname: Workman
mesh_terms: D000818:Animals; D004791:Enzyme Inhibitors / Q000494:pharmacology*; D005260:Female; D005663:Furans / Q000494:pharmacology*; D005909:Glioblastoma / Q000188:drug therapy*; D006801:Humans; D007191:Indazoles / Q000494:pharmacology*; D010051:Ovarian Neoplasms / Q000188:drug therapy*; D000081082:Phosphoinositide-3 Kinase Inhibitors; D011725:Pyridines / Q000494:pharmacology*; D011743:Pyrimidines / Q000008:administration & dosage* / Q000494:pharmacology*; D013449:Sulfonamides / Q000494:pharmacology*; D013876:Thiophenes / Q000008:administration & dosage*
chemical_list: D004791:Enzyme Inhibitors; D005663:Furans; D007191:Indazoles; D000081082:Phosphoinositide-3 Kinase Inhibitors; D011725:Pyridines; D011743:Pyrimidines; D013449:Sulfonamides; D013876:Thiophenes
references.citation: Cancer Res. 2010 Mar 15;70(6):2146-57
references.pmid: 20179189
references.citation: J Med Chem. 2008 Sep 25;51(18):5522-32
references.pmid: 18754654
references.citation: Curr Med Chem. 2011;18(18):2686-714
references.pmid: 21649578
references.citation: Bioorg Med Chem Lett. 2007 May 1;17(9):2438-42
references.pmid: 17339109
references.citation: Cancer Res. 2007 Jun 15;67(12):5840-50
references.pmid: 17575152